Bronchodilators known as beta-2 agonists are extensively used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Although beta-2 agonists have been linked to a lower incidence of Parkinson's disease in earlier research, this link was not detected in a recent registe
Dipa Karmakar tested positive for higenamine (S3. Beta-2 Agonists as per the World Anti-Doping Agency prohibited list). The positive sample was collected on behalf of the Federation Internationale de Gymnastique (FIG) in the scope of an out-of-competition control on 11th October 2021. Higena